Page 3 - James Kihara News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from James kihara. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In James Kihara Today - Breaking & Trending Today

ACADIA Pharmaceuticals' (ACAD) "Market Perform" Rating Reaffirmed at Oppenheimer

Oppenheimer restated their market perform rating on shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) in a research report released on Monday, Benzinga reports. The brokerage currently has a $19.00 target price on the biopharmaceutical company’s stock. A number of other brokerages have also recently commented on ACAD. Mizuho cut shares of ACADIA Pharmaceuticals from […] ....

United States , Zurcher Kantonalbank Zurich Cantonalbank , James Kihara , Stephen Davis , Mirae Asset Global Investments Co , Morgan Stanley , Pharmaceuticals Stock Down , Pharmaceuticals Inc , Pharmaceuticals Company Profile , Emerald Mutual Fund Advisers , Raymond James Associates , Pharmaceuticals Daily , Emerald Advisers , Royal Bank , Free Report , Moderate Buy , Stock Down , Get Free Report , Kantonalbank Zurich Cantonalbank , Asset Global Investments , Emerald Mutual Fund Advisers Trust , Mutual Fund Advisers Trust , Acadia Pharmaceuticals , Nasdaq Acad , Reiterated Rating , Oppenheimer Holdings Inc ,

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives $35.82 Consensus Target Price from Brokerages

Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) have earned an average rating of “Moderate Buy” from the fifteen research firms that are presently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average 1 […] ....

United States , James Kihara , Robertw Baird , Stephen Davis , Pharmaceuticals Daily , Norges Bank , Needham Company , Pharmaceuticals Inc , Fred Alger Management , Mg Investment Management Ltd , Pharmaceuticals Price Performance , Royal Bank , Eventide Asset Management , Get Free Report , Marketbeat Ratings , Alger Management , Asset Management , Get Free , Acadia Pharmaceuticals , Nasdaq Acad ,

ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Rating Reaffirmed by Cantor Fitzgerald

ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report)‘s stock had its “overweight” rating reissued by equities research analysts at Cantor Fitzgerald in a research report issued on Tuesday, Benzinga reports. They presently have a $37.00 target price on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price target would indicate a potential upside of 118.16% from the stock’s […] ....

United States , Stephen Davis , James Kihara , Legato Capital Management , Pharmaceuticals Trading Down , Pharmaceuticals Daily , Cantor Fitzgerald , China Universal Asset Management Co , Securities Exchange Commission , Acadian Asset Management , Quest Partners , Pharmaceuticals Inc , Royal Bank , Acadia Pharmaceuticals , Get Free Report , Trading Down , Exchange Commission , Universal Asset Management , Management Fondsmaeglerselskab , Asset Management , Nasdaq Acad , Reiterated Rating ,

State of New Jersey Common Pension Fund D Purchases 19,703 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

State of New Jersey Common Pension Fund D Purchases 19,703 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , New Jersey , James Kihara , Markc Schneyer , Morgan Stanley , Pharmaceuticals Profile , Emerald Advisers , Pharmaceuticals Trading , Emerald Mutual Fund Advisers , Cantor Fitzgerald , Pharmaceuticals Inc , Jpmorgan Chase Co , Royal Bank , Jersey Common Pension Fund , Exchange Commission , Pharmaceuticals Daily , Jupiter Asset Management Ltd , Fred Alger Management , Free Report , Alger Management , Mutual Fund Advisers Trust , Jupiter Asset Management , Asset Management , Get Free Report , Visit Holdingschannel ,

ACADIA Pharmaceuticals (NASDAQ:ACAD) Sets New 52-Week Low at $16.60

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report)’s stock price reached a new 52-week low during trading on Tuesday . The stock traded as low as $16.60 and last traded at $16.74, with a volume of 1475997 shares. The stock had previously closed at $16.99. Analyst Ratings Changes A number of analysts recently issued reports […] ....

United States , Brendan Teehan , James Kihara , Zurcher Kantonalbank Zurich Cantonalbank , Pharmaceuticals Inc , Pharmaceuticals Daily , Acadia Pharmaceuticals Inc , Mirae Asset Global Investments Co , Raymond James Associates , Pharmaceuticals Trading Down , Sg Americas Securities , Pharmaceuticals Company Profile , Emerald Advisers , Securities Exchange Commission , Royal Bank , Get Free Report , Trading Down , Exchange Commission , Kantonalbank Zurich Cantonalbank , Asset Global Investments , Acadia Pharmaceuticals , Nasdaq Acad ,